Trinity Biotech plc

Contributing Author

Recent Articles by Trinity Biotech plc

Sep-09	Trinity Biotech's Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center Infrastructure TRIB -11.70% GlobeNewswire
Aug-28	Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update TRIB GlobeNewswire
Aug-17	Trinity Biotech's Trinovium Subsidiary Agrees to Collaborate with Echelon Data Centres to Develop Advanced Liquid Cooling Solutions for AI Infrastructure TRIB GlobeNewswire
Aug-14	Trinity Biotech Secures Additional $7.0 Million Investment from Perceptive Advisors and Regains Compliance with Nasdaq Minimum Bid Price Requirement TRIB GlobeNewswire
Jul-22	Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology TRIB -15.44% GlobeNewswire
Jul-22	Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change TRIB -15.44% GlobeNewswire
Jul-02	New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring TRIB +5.49% GlobeNewswire
Jun-30	Trinity Biotech's Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling TRIB -6.94% GlobeNewswire
Jun-29	Trinity Biotech Terminates Standby Equity Purchase Agreement with Yorkville TRIB +15.73% GlobeNewswire
Jun-23	Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market TRIB -38.95% GlobeNewswire
Jun-16	Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results TRIB -15.83% GlobeNewswire
May-01	Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations TRIB GlobeNewswire
Mar-23	Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture Prostate Cancer Test TRIB -5.14% GlobeNewswire
Mar-18	Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjogren's Syndrome TRIB -7.03% GlobeNewswire
Mar-12	Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System TRIB GlobeNewswire
Mar-11	Trinity Biotech Senior Executives to Attend ATTD 2026 to Advance Collaborations Following Strong Progress in CGM Program TRIB +10.04% GlobeNewswire
Mar-10	Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform TRIB -6.66% GlobeNewswire
Mar-10	Trinity Biotech Provides Business and Trading Update TRIB -6.66% GlobeNewswire
Feb-25	Trinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives TRIB GlobeNewswire
Feb-20	Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares TRIB GlobeNewswire
Feb-13	Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement TRIB GlobeNewswire
Feb-10	Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation TRIB +8.75% TRIB -5.40% GlobeNewswire
Feb-10	Trinity Biotech Glucose Monitoring Innovation Achieves Unique Global Recognition: Diabetes Care Premier Hb9210 HbA1c Analyser Becomes the Only System Awarded Prestigious IFCC Gold Classification for 2026 TRIB +8.75% GlobeNewswire
Dec-23	Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives TRIB +43.50% GlobeNewswire
Dec-23	Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests TRIB +43.50% GlobeNewswire
Dec-15	Trinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances TRIB -12.15% GlobeNewswire
Nov-18	Trinity Biotech Secures Major Regulatory Approval for Offshored and Outsourced Manufacturing of Its Market Leading Uni-Gold Rapid HIV Test, Further Accelerating Financial Performance Transformation TRIB GlobeNewswire
Nov-14	Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test TRIB GlobeNewswire
Oct-27	Trinity Biotech Welcomes Perceptive Advisor's Indication of Potential Debt-to-Equity Conversion - Strengthening Balance Sheet and Supporting Growth TRIB GlobeNewswire
Sep-02	Trinity Biotech Regains Compliance with Nasdaq Listing Requirements TRIB GlobeNewswire
Aug-21	Trinity Biotech Appoints Paul Tivnan as Non-Executive Director TRIB -10.34% GlobeNewswire
Aug-20	Regulatory Approval Granted for Commencement of Trinity Biotech's Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation TRIB +27.01% GlobeNewswire
Aug-14	Trinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara Preeclampsia Testing Service TRIB +89.05% GlobeNewswire
Aug-12	Trinity Biotech Achieves Breakthrough Clinical Trial Results for Redesigned CGM Sensor TRIB +35.59% GlobeNewswire
Aug-07	Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service TRIB +7.41% GlobeNewswire
Jul-24	Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market TRIB GlobeNewswire
Jul-01	Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround TRIB +7.42% GlobeNewswire
Jun-24	Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation TRIB +27.04% GlobeNewswire
May-15	Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update TRIB GlobeNewswire

Trinity Biotech plc

Recent Articles by Trinity Biotech plc

Upgrade your Finviz experience